Heterogeneity of the midbrain dopamine system

Neurology

Volumn 85, Issue 20, 2015, Pages 1795-1805

  Hassan, Anhar ^a   Benarroch, Eduardo E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; DOPAMINE; DOPAMINE 2 RECEPTOR;

ANATOMICAL VARIATION; ANXIETY DISORDER; APATHY; ARTICLE; ASSOCIATION; BRAIN CORTEX; COGNITIVE DEFECT; CONNECTOME; CORPUS STRIATUM; DENDRITE; DEPRESSION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; EFFERENT NERVE; EVOKED RESPONSE; EXECUTIVE FUNCTION; FEEDBACK SYSTEM; FIRING RATE; HIPPOCAMPUS; HUMAN; IMPULSE CONTROL DISORDER; INSTRUMENTAL LEARNING; LEARNING; MEMORY; MEMORY DISORDER; MENTAL DISEASE; MESENCEPHALON; MOTIVATION; MOTOR PERFORMANCE; NERVE CELL; NEUROANATOMY; NEUROPATHOLOGY; NEUROPHYSIOLOGY; PARKINSON DISEASE; PAVLOVIAN LEARNING; PREFRONTAL CORTEX; PRIORITY JOURNAL; REWARD; SALIENCE NETWORK; SENSORY NERVE; SPIKE WAVE; STATE DEPENDENT LEARNING; ACTION POTENTIAL; ANIMAL; MENTAL DISORDERS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ACTION POTENTIALS; ANIMALS; DOPAMINE; DOPAMINERGIC NEURONS; HUMANS; MENTAL DISORDERS; MESENCEPHALON; PARKINSON DISEASE;

EID: 84947461530     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002137     Document Type: Article

References (104)

1. Bromberg-Martin ES, Matsumoto M, Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010; 68: 815-834
2. Haber SN. The place of dopamine in the cortico-basal ganglia circuit. Neuroscience 2014; 282C: 248-257
3. Yetnikoff L, Lavezzi HN, Reichard RA, Zahm DS. An update on the connections of the ventral mesencephalic dopaminergic complex. Neuroscience 2014; 282C: 23-48
4. Schultz W. Behavioral dopamine signals. Trends Neurosci 2007; 30: 203-210
5. Schultz W. Updating dopamine reward signals. Curr Opin Neurobiol 2013; 23: 229-238
6. Grace AA, Floresco SB, Goto Y, Lodge DJ. Regulation of firing of dopaminergic neurons and control of goaldirected behaviors. Trends Neurosci 2007; 30: 220-227
7. Matsumoto M, Hikosaka O. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature 2009; 459: 837-841
8. Salamone JD, Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron 2012; 76: 470-485
9. Roeper J. Dissecting the diversity of midbrain dopamine neurons. Trends Neurosci 2013; 36: 336-342
10. Paladini CA, Roeper J. Generating bursts (and pauses) in the dopamine midbrain neurons. Neuroscience 2014; 282C: 109-121
11. Marinelli M, McCutcheon JE. Heterogeneity of dopamine neuron activity across traits and states. Neuroscience 2014; 282C: 176-197
12. Lammel S, Lim BK, Malenka RC. Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 2014; 76: 351-359
13. Dragicevic E, Schiemann J, Liss B. Dopamine midbrain neurons in health and Parkinson's disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels. Neuroscience 2015; 284: 798-814
14. Voon V, Dalley JW. Parkinson disease: impulsive choice-Parkinson disease and dopaminergic therapy. Nat Reviews Neurol 2011; 7: 541-542
15. Calabresi P, Castrioto A, Di Filippo M, Picconi B. New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. Lancet Neurol 2013; 12: 811-821
16. Puig MV, Antzoulatos EG, Miller EK. Prefrontal dopamine in associative learning and memory. Neuroscience 2014; 282C: 217-229
17. Kim HF, Hikosaka O. Parallel basal ganglia circuits for voluntary and automatic behaviour to reach rewards. Brain 2015; 138: 1776-1800
18. Pignatelli M, Bonci A. Role of dopamine neurons in reward and aversion: a synaptic plasticity Perspective. Neuron 2015; 86: 1145-1157
19. Li X, Qi J, Yamaguchi T, Wang HL, Morales M. Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties. Brain Struct Funct 2013; 218: 1159-1176
20. Morales M, Root DH. Glutamate neurons within the midbrain dopamine regions. Neuroscience 2014; 282C: 60-68
21. Tritsch NX, Ding JB, Sabatini BL. Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature 2012; 490: 262-266
22. McRitchie DA, Hardman CD, Halliday GM. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol 1996; 364: 121-150
23. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain: I: nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 1999; 122: 1421-1436
24. Watabe-Uchida M, Zhu L, Ogawa SK, Vamanrao A, Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 2012; 74: 858-873
25. Garcia-Cabezas MA, Rico B, Sanchez-Gonzalez MA, Cavada C. Distribution of the dopamine innervation in the macaque and human thalamus. NeuroImage 2007; 34: 965-984
26. Hong S, Hikosaka O. Pedunculopontine tegmental nucleus neurons provide reward, sensorimotor, and alerting signals to midbrain dopamine neurons. Neuroscience 2014; 282C: 139-155
27. Overton PG, Vautrelle N, Redgrave P. Sensory regulation of dopaminergic cell activity: Phenomenology, circuitry and function. Neuroscience 2014; 282C: 1-12
28. Crittenden JR, Graybiel AM. Basal ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front Neuroanat 2011; 5: 59
29. Jhou TC, Fields HL, Baxter MG, Saper CB, Holland PC. The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron 2009; 61: 786-800
30. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997; 275: 1593-1599
31. Shi WX. Electrophysiological characteristics of dopamine neurons: a 35-year update. J Neural Transm Suppl 2009: 103-119
32. Durante P, Cardenas CG, Whittaker JA, Kitai ST, Scroggs RS. Low-threshold L-type calcium channels in rat dopamine neurons. J Neurophysiol 2004; 91: 1450-1454
33. Guzman JN, Sanchez-Padilla J, Chan CS, Surmeier DJ. Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci 2009; 29: 11011-11019
34. Surmeier DJ, Guzman JN, Sanchez-Padilla J, Schumacker PT. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease. Neuroscience 2011; 198: 221-231
35. Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011; 63: 182-217
36. Ford CP. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 2014; 282C: 13-22
37. Beckstead MJ, Williams JT. Long-term depression of a dopamine IPSC. J Neurosci 2007; 27: 2074-2080
38. Morikawa H, Paladini CA. Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms. Neuroscience 2011; 198: 95-111
39. Schiemann J, Schlaudraff F, Klose V, et al. K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration. Nat Neurosci 2012; 15: 1272-1280
40. Lobb CJ, Wilson CJ, Paladini CA. A dynamic role for GABA receptors on the firing pattern of midbrain dopaminergic neurons. J Neurophysiol 2010; 104: 403-413
41. Covey DP, Roitman MF, Garris PA. Illicit dopamine transients: reconciling actions of abused drugs. Trends Neurosci 2014; 37: 200-210
42. Schultz W, Romo R. Dopamine neurons of the monkey midbrain: contingencies of responses to stimuli eliciting immediate behavioral reactions. J Neurophysiol 1990; 63: 607-624
43. Zaghloul KA, Blanco JA, Weidemann CT, et al. Human substantia nigra neurons encode unexpected financial rewards. Science 2009; 323: 1496-1499
44. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 1998; 28: 309-369
45. Schultz W. Dopamine signals for reward value and risk: basic and recent data. Behav Brain Funct 2010; 6: 24
46. Grace AA. Physiology of the normal and dopaminedepleted basal ganglia: insights into levodopa pharmacotherapy. Mov Disord 2008; 23(suppl 3): S560-S569
47. Tsai HC, Zhang F, Adamantidis A, et al. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 2009; 324: 1080-1084
48. Tritsch NX, Sabatini BL. Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 2012; 76: 33-50
49. Gerfen CR, Surmeier DJ. Modulation of striatal projection systems by dopamine. Ann Rev Neurosci 2011; 34: 441-466
50. Cools R. Dopaminergic control of the striatum for highlevel cognition. Curr Opin Neurobiol 2011; 21: 402-407
51. Liljeholm M, O'Doherty JP. Contributions of the striatum to learning, motivation, and performance: an associative account. Trends Cognit Sci 2012; 16: 467-475
52. Morita K, Morishima M, Sakai K, Kawaguchi Y. Reinforcement learning: computing the temporal difference of values via distinct corticostriatal pathways. Trends Neurosci 2012; 35: 457-467
53. Puig MV, Rose J, Schmidt R, Freund N. Dopamine modulation of learning and memory in the prefrontal cortex: insights from studies in primates, rodents, and birds. Front Neural Circuits 2014; 8: 93
54. Dreyer JK, Herrik KF, Berg RW, Hounsgaard JD. Influence of phasic and tonic dopamine release on receptor activation. J Neurosci 2010; 30: 14273-14283
55. Nakanishi S, Hikida T, Yawata S. Distinct dopaminergic control of the direct and indirect pathways in reward-based and avoidance learning behaviors. Neuroscience 2014; 282C: 49-59
56. O'Doherty J, Dayan P, Schultz J, Deichmann R, Friston K, Dolan RJ. Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science 2004; 304: 452-454
57. Ilango A, Kesner AJ, Keller KL, Stuber GD, Bonci A, Ikemoto S. Similar roles of substantia nigra and ventral tegmental dopamine neurons in reward and aversion. J Neurosci 2014; 34: 817-822
58. Goto Y, Grace AA. Limbic and cortical information processing in the nucleus accumbens. Trends Neurosci 2008; 31: 552-558
59. Liljeholm M, Tricomi E, O'Doherty JP, Balleine BW. Neural correlates of instrumental contingency learning: differential effects of action-reward conjunction and disjunction. J Neurosci 2011; 31: 2474-2480
60. Tricomi E, Balleine BW, O'Doherty JP. A specific role for posterior dorsolateral striatum in human habit learning. Eur J Neurosci 2009; 29: 2225-2232
61. Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW, Robbins TW. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 2008; 363: 3125-3135
62. Creed MC, Luscher C. Drug-evoked synaptic plasticity: beyond metaplasticity. Curr Opin Neurobiol 2013; 23: 553-558
63. Schmidt L, Lebreton M, Clery-Melin ML, Daunizeau J, Pessiglione M. Neural mechanisms underlying motivation of mental versus physical effort. PLoS Biol 2012; 10: e1001266
64. Chib VS, De Martino B, Shimojo S, O'Doherty JP. Neural mechanisms underlying paradoxical performance for monetary incentives are driven by loss aversion. Neuron 2012; 74: 582-594
65. Stopper CM, Tse MT, Montes DR, Wiedman CR, Floresco SB. Overriding phasic dopamine signals redirects action selection during risk/reward decision making. Neuron 2014; 84: 177-189
66. Hansen N, Manahan-Vaughan D. Dopamine D1/D5 receptors mediate informational saliency that promotes persistent hippocampal long-term plasticity. Cereb Cortex 2014; 24: 845-858
67. Hamilton TJ, Wheatley BM, Sinclair DB, Bachmann M, Larkum ME, Colmers WF. Dopamine modulates synaptic plasticity in dendrites of rat and human dentate granule cells. Proc Natl Acad Sci USA 2010; 107: 18185-18190
68. Lisman JE, Grace AA. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 2005; 46: 703-713
69. Matsumoto M, Takada M. Distinct representations of cognitive and motivational signals in midbrain dopamine neurons. Neuron 2013; 79: 1011-1024
70. Durstewitz D, Seamans JK. The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia. Biol Psychiatry 2008; 64: 739-749
71. Liss B, Haeckel O, Wildmann J, Miki T, Seino S, Roeper J. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci 2005; 8: 1742-1751
72. Subramaniam M, Althof D, Gispert S, et al. Mutant alpha-synuclein enhances firing frequencies in dopamine substantia nigra neurons by oxidative impairment of A-type potassium channels. J Neurosci 2014; 34: 13586-13599
73. Parent A, Lavoie B. The heterogeneity of the mesostriatal dopaminergic system as revealed in normal and parkinsonian monkeys. Adv Neurol 1993; 60: 25-33
74. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301
75. Hurley MJ, Brandon B, Gentleman SM, Dexter DT. Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins. Brain 2013; 136: 2077-2097
76. Cai H, Liu G, Sun L, Ding J. Aldehyde dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease. Trans Neurodegen 2014; 3: 27
77. Galter D, Buervenich S, Carmine A, Anvret M, Olson L. ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia. Neurobiol Dis 2003; 14: 637-647
78. Stefanova ED, Kostic VS, Ziropadja L, Markovic M, Ocic GG. Visuomotor skill learning on serial reaction time task in patients with early Parkinson's disease. Mov Disord 2000; 15: 1095-1103
79. Wu T, Hallett M. A functional MRI study of automatic movements in patients with Parkinson's disease. Brain 2005; 128: 2250-2259
80. Nobili F, Campus C, Arnaldi D, et al. Cognitivenigrostriatal relationships in de novo, drug-naive Parkinson's disease patients: a [I-123]FP-CIT SPECT study. Mov Disord 2010; 25: 35-43
81. Picco A, Morbelli S, Piccardo A, et al. Brain (18)FDOPA PET and cognition in de novo Parkinson's disease. Eur J Nuc Med Mol Imag 2015; 42: 1062-1070
82. Christopher L, Marras C, Duff-Canning S, et al. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment. Brain 2014; 137: 565-575
83. Costa C, Sgobio C, Siliquini S, et al. Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. Brain 2012; 135: 1884-1899
84. Christopher L, Duff-Canning S, Koshimori Y, et al. Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease. Ann Neurol 2015; 77: 269-280
85. Voon V, Gao J, Brezing C, et al. Dopamine agonists and risk: impulse control disorders in Parkinson's disease. Brain 2011; 134: 1438-1446
86. Potenza MN. Review: the neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci 2008; 363: 3181-3189
87. Evans AH, Pavese N, Lawrence AD, et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006; 59: 852-858
88. O'Sullivan SS, Wu K, Politis M, et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011; 134: 969-978
89. Steeves TD, Miyasaki J, Zurowski M, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009; 132: 1376-1385
90. Dardou D, Chassain C, Durif F. Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats. Front Neurosci 2014; 8: 437
91. Gerlach M, Double K, Arzberger T, Leblhuber F, Tatschner T, Riederer P. Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J Neural Transm 2003; 110: 1119-1127
92. Tokunaga N, Choudhury ME, Nishikawa N, et al. Pramipexole upregulates dopamine receptor D(2) and D(3) expression in rat striatum. J Pharmacol Sci 2012; 120: 133-137
93. Boileau I, Payer D, Chugani B, et al. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(1)-propyl-hexahydronaphtho-oxazin and [11C]raclopride. Addiction 2013; 108: 953-963
94. van Eimeren T, Pellecchia G, Cilia R, et al. Druginduced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 2010; 75: 1711-1716
95. Rodriguez-Oroz MC, Lopez-Azcarate J, Garcia-Garcia D, et al. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain 2011; 134: 36-49
96. Cao JL, Covington HE III, Friedman AK, et al. Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action. J Neurosci 2010; 30: 16453-16458
97. Skorvanek M, Gdovinova Z, Rosenberger J, et al. The associations between fatigue, apathy, and depression in Parkinson's disease. Acta Neurol Scand 2015; 131: 80-87
98. Barone P, Poewe W, Albrecht S, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebocontrolled trial. Lancet Neurol 2010; 9: 573-580
99. Thobois S, Lhommee E, Klinger H, et al. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain 2013; 136: 1568-1577
100. Santangelo G, Vitale C, Picillo M, et al. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients. Parkinsonism Relat Disord 2015; 21: 489-493
101. Vriend C, Raijmakers P, Veltman DJ, et al. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 2014; 85: 159-164
102. Ahlskog JE. Cheaper, simpler, and better: tips for treating seniors with Parkinson disease. Mayo Clin Proc 2011; 86: 1211-1216
103. Rektorova I, Balaz M, Svatova J, et al. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study. Clin Neuropharmacol 2008; 31: 261-266
104. Moraga-Amaro R, Gonzalez H, Pacheco R, Stehberg J. Dopamine receptor D3 deficiency results in chronic depression and anxiety. Behav Brain Res 2014; 274: 186-193